Mobility Assistive Equipment (MAE) — NCD 219 | CMS Coverage Update

TL;DR: The Centers for Medicare & Medicaid Services modified NCD 219 governing mobility assistive equipment coverage, with an effective date of March 7, 2026. Here's what billing teams need to know before claims start moving through adjudication.

CMS updated NCD 219 in its Medicare system, covering mobility assistive equipment (MAE) — a category that includes canes, crutches, walkers, manual wheelchairs, power wheelchairs, and scooters. This coverage policy uses an algorithmic, step-by-step clinical decision process to determine which device a beneficiary qualifies for. The policy does not list specific HCPCS codes in this version of the document, but your durable medical equipment billing workflows are directly in scope.

CMS Mobility Assistive Equipment Coverage Criteria and Medical Necessity Requirements 2026

NCD 219 is the National Coverage Determination governing Medicare coverage of mobility assistive equipment for home use. The Centers for Medicare & Medicaid Services revised this policy on March 7, 2026. The core coverage policy has not been gutted — MAE remains a covered durable medical equipment benefit — but the criteria that determine which device a beneficiary gets remain specific, sequential, and easy to get wrong.

CMS covers MAE when a beneficiary has a personal mobility deficit that impairs their ability to participate in mobility-related activities of daily living (MRADLs). Those MRADLs are defined concretely: toileting, feeding, dressing, grooming, and bathing in customary locations within the home. "Customary locations" is doing real work in that sentence. If a beneficiary can perform these activities in a modified location but not the usual one, they still qualify.

The medical necessity standard here is not just "the patient has trouble walking." CMS requires a qualifying mobility limitation — one that either prevents the beneficiary from completing MRADLs entirely, places them at heightened risk of morbidity or mortality when attempting MRADLs, or prevents completion within a reasonable time frame. Any one of those three prongs clears the first gate. Your documentation needs to show which prong applies. Vague functional language will get the claim denied.

The Clinical Criteria Algorithm — How Coverage Is Actually Determined

This is where mobility assistive equipment billing gets complicated. CMS uses a sequential, algorithmic process to determine not just whether MAE is covered, but which type of MAE is appropriate. The questions must be worked through in order. You cannot jump to "patient needs a power wheelchair" without first establishing that simpler options are inadequate.

The algorithm starts at question one: Does the beneficiary have a mobility limitation that significantly impairs participation in one or more MRADLs at home? This is the medical necessity gate. If the answer is no, nothing else matters.

Question two asks whether other conditions limit the beneficiary's ability to participate in MRADLs at home. This is where comorbidities come in. CMS explicitly names examples: muscular spasticity, cognitive deficits, caregiver availability, and the physical layout of the home — surfaces, obstacles, room configuration. These factors shape which device is appropriate. A patient with significant cognitive deficits may not be a safe candidate for a power wheelchair. A patient who lives alone with no caregiver faces different constraints than one with daily support. The algorithm accounts for all of it.

The living environment is not a soft clinical consideration here. It is a documented coverage criterion. If your clinical staff are not capturing home environment details in the face-to-face evaluation notes, your claims are exposed.

Prior Authorization and Documentation Requirements

NCD 219 does not specify a blanket prior authorization requirement at the national level. However, your Medicare Administrative Contractor (MAC) may have a Local Coverage Determination (LCD) that layers additional prior authorization requirements on top of the NCD. Check with your MAC before submitting claims for power wheelchairs and scooters especially — those categories have historically drawn the most scrutiny.

The face-to-face examination requirement is where most MAE claims fall apart. The treating practitioner must document the beneficiary's mobility deficit, their living environment, and the rationale for the selected device. The clinical notes need to mirror the algorithm. If the note says "patient needs a wheelchair" without walking through the sequential criteria, you are looking at a claim denial.

CMS MAE Exclusions and Non-Covered Indications

NCD 219 does not define a long list of blanket exclusions. The coverage policy is structured around the algorithm, so coverage or non-coverage flows from whether the beneficiary clears each sequential criterion — not from a separate exclusion list.

That said, two situations clearly fall outside covered indications. First, MAE used exclusively outside the home is not covered under this NCD. Medicare's DME benefit for MAE is specifically tied to in-home use and MRADLs performed in the home. If the clinical documentation focuses on community mobility rather than home function, the claim will not survive scrutiny.

Second, a beneficiary who does not have a qualifying mobility limitation — meaning their functional deficit does not meet any of the three prongs under question one of the algorithm — is not a covered beneficiary under this policy. Ordering a walker or scooter for a patient who is ambulatory at home without significant MRADL impairment is not a covered service. This sounds obvious, but it is exactly the pattern that drives CMS audit findings.

Coverage Indications at a Glance

CMS Mobility Assistive Equipment Billing Guidelines and Action Items 2026

The real issue here is documentation. This policy has been around since 2005, and the algorithm has not fundamentally changed. What gets billing teams in trouble is not a misunderstanding of the policy — it is documentation that does not map cleanly to the sequential criteria. Here is what to do before you submit claims dated March 7, 2026 or later.

If you are managing a large DME supplier operation or a complex rehab technology program, talk to your compliance officer before the March 7, 2026 effective date. The documentation requirements under NCD 219 interact with MAC-level LCDs in ways that are specific to your payer mix and device categories.

CPT, HCPCS, and ICD-10 Codes for Mobility Assistive Equipment Under NCD 219

The NCD 219 policy document as modified on March 7, 2026 does not enumerate specific HCPCS or CPT codes within the policy text itself. This is consistent with how CMS structures many equipment NCDs — the coverage criteria are set at the national level, and the specific HCPCS codes (typically the K, E, and A code series for wheelchairs, walkers, and related MAE) are mapped to the policy through your MAC's LCD and associated billing and coding articles.

Do not assume a code is covered under NCD 219 just because it falls in the MAE category. Pull the current LCD for MAE from your MAC, cross-reference the associated billing and coding article, and confirm which HCPCS codes your MAC maps to this NCD. That document will list the covered codes by device type and complexity level.

If your compliance officer or billing consultant asks why there are no codes in this post — that is why. The policy data for NCD 219 v2 does not include a code table. Fabricating codes here would be worse than omitting them.